AMCA
DXCM icon

Arthur M. Cohen & Associates’s DexCom DXCM Stock Holding History

Arthur M. Cohen & Associates’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,458
Closed -$294K – 139
2024
Q3 		$294K Sell
4,458
-6,020
-57% -$494K 0.05% 113
2024
Q2 		$1.19M Buy
10,478
+636
+6% +$80.4K 0.22% 57
2024
Q1 		$1.37M Sell
9,842
-1,670
-15% -$210K 0.29% 48
2023
Q4 		$1.43M Sell
11,512
-340
-3% -$34.7K 0.34% 45
2023
Q3 		$1.11M Sell
11,852
-280
-2% -$31.6K 0.28% 53
2023
Q2 		$1.56M Sell
12,132
-350
-3% -$42.3K 0.39% 42
2023
Q1 		$1.45M Sell
12,482
-360
-3% -$40.3K 0.39% 39
2022
Q4 		$1.45M Sell
12,842
-390
-3% -$42.8K 0.4% 36
2022
Q3 		$1.07M Buy
13,232
+1,670
+14% +$141K 0.29% 49
2022
Q2 		$862K Sell
11,562
-2,210
-16% -$202K 0.21% 59
2022
Q1 		$1.76M Buy
13,772
+1,308
+10% +$143K 0.37% 40
2021
Q4 		$1.67M Buy
12,464
+80
+0.6% +$11.5K 0.31% 48
2021
Q3 		$1.69M Buy
+12,384
New +$1.56M 0.34% 44

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Arthur M. Cohen & Associates's DXCM Position: Q4 2024 in Review

Arthur M. Cohen & Associates sold out of DexCom (DXCM) in Q4 2024, closing a stake of 4,458 shares — an estimated $294K sold.

Arthur M. Cohen & Associates first reported a position in DXCM in Q3 2021 and held it in 13 quarters. The position peaked at $1.76M in Q1 2022. 951 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Arthur M. Cohen & Associates reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Arthur M. Cohen & Associates sold 4,458 DexCom shares in Q4 2024, an estimated $294K.
  • Arthur M. Cohen & Associates first reported a position in DexCom in Q3 2021 and held it in 13 quarters.
  • Arthur M. Cohen & Associates's DexCom position peaked at $1.76M in Q1 2022.
  • 951 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Arthur M. Cohen & Associates's 13F filing for Q4 2024, filed 15 Jan 2025.